Over-expression of c-kit in a primary leiomyosarcoma of the thyroid gland

被引:17
作者
Day, An-Shiou
Lou, Pei-Jen
Lin, Wei-Chou
Chou, Chi-Chun
机构
[1] Cardinal Tien Hosp, Dept Otolaryngol, Yung Ho Branch, YungHo City 234, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
关键词
leiomyosarcoma; thyroid gland; c-kit; tyrosine kinase inhibitor;
D O I
10.1007/s00405-007-0242-z
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Primary leiomyosarcoma of the thyroid gland is rare. In this paper, we report a case of high-grade leiomyosarcoma of the thyroid gland in a 43-year-old man. Lung metastasis was also noted in this patient. Despite of aggressive surgical treatment, the patient died of uncontrolled local recurrent disease 6 months after the initial operation. Immunohistochemical studies showed the tumor cells were positive for c-kit proto-oncogene product. Imatinib mesylate was used as a post-operative adjuvant treatment but the response was poor. The role of tyrosine kinase inhibitors on the treatment of thyroid leiomyosarcomas is still unclear because this is the first report of c-kit over-expression in such tumors. Nevertheless, our results show that c-kit over-expression might not be an indicator of good response to imatinib mesylate treatment in thyroid leiomyosarcomas.
引用
收藏
页码:705 / 708
页数:4
相关论文
共 28 条
[1]   Paraffin section detection of the c-kit gene product (CD117) in human tissues:: Value in the diagnosis of mast cell disorders [J].
Arber, DA ;
Tamayo, R ;
Weiss, LM .
HUMAN PATHOLOGY, 1998, 29 (05) :498-504
[2]   Tyrosine kinase inhibitors: Why does the current process of clinical development not apply to them? [J].
Arteaga, CL ;
Baselga, J .
CANCER CELL, 2004, 5 (06) :525-531
[3]   LEIOMYOSARCOMA OF THE THYROID - IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL-STUDY [J].
CHETTY, R ;
CLARK, SP ;
DOWLING, JP .
PATHOLOGY, 1993, 25 (02) :203-205
[4]  
Dagher R, 2002, CLIN CANCER RES, V8, P3034
[5]  
Ferlito A, 2001, ACTA OTO-LARYNGOL, V121, P324
[6]   Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: Analysis of results in 140 surgically resected patients [J].
Yoshiya Fujimoto ;
Yukihiro Nakanishi ;
Kimio Yoshimura ;
Tadakazu Shimoda .
Gastric Cancer, 2003, 6 (1) :39-48
[7]   Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies [J].
Heinrich, MC ;
Blanke, CD ;
Druker, BJ ;
Corless, CL .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) :1692-1703
[8]   THE EXPRESSION OF C-KIT PROTEIN IN HUMAN ADULT AND FETAL TISSUES [J].
HORIE, K ;
FUJITA, J ;
TAKAKURA, K ;
KANZAKI, H ;
SUGINAMI, H ;
IWAI, M ;
NAKAYAMA, H ;
MORI, T .
HUMAN REPRODUCTION, 1993, 8 (11) :1955-1962
[9]   THYROID-TUMORS - CYTOMORPHOLOGY OF MEDULLARY, CLINICALLY ANAPLASTIC, AND MISCELLANEOUS THYROID NEOPLASMS [J].
KAUR, A ;
JAYARAM, G .
DIAGNOSTIC CYTOPATHOLOGY, 1990, 6 (06) :383-389
[10]  
KAWAHARA E, 1988, CANCER-AM CANCER SOC, V62, P2558, DOI 10.1002/1097-0142(19881215)62:12<2558::AID-CNCR2820621218>3.0.CO